KD

Kamlesh Dungarchand Jain

Active Director Director DIN 10150150
DIN 10150150 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamlesh Dungarchand Jain

Data last updated:

Kamlesh Dungarchand Jain is a Director at Deltas Pharma Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 10150150
Primary Designation Director
Industry Pharma
First Appointment 20 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20252025Active

Directorship timeline

Open interactive timeline →
Deltas Pharma Lifesciences Private Limited
Premium access

Shareholding and investment profile for Kamlesh Dungarchand Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Dungarchand Jain

Kamlesh Dungarchand Jain currently holds 1 directorship: Deltas Pharma Lifesciences Private Limited (Director, since 20 Feb 2025).

Kamlesh Dungarchand Jain was first appointed on 20 Feb 2025 as Director at Deltas Pharma Lifesciences Private Limited.

The current boards of Kamlesh Dungarchand Jain's companies include Babuulal Bhavarlal Jain (Deltas Pharma Lifesciences Private Limited), Bharat Dungarchand Jain (Deltas Pharma Lifesciences Private Limited), Preet Suresh Jain (Deltas Pharma Lifesciences Private Limited), Sureshkumar Babulal Jain (Deltas Pharma Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available